☆ 4.1 Letter

Opportunities for Deprescribing Statins in Patients with Poor Cancer Prognosis

JOURNAL OF PALLIATIVE MEDICINE (2013)

Journal

JOURNAL OF PALLIATIVE MEDICINE

Volume 16, Issue 11, Pages 1328-1328

Publisher

MARY ANN LIEBERT, INC

DOI: 10.1089/jpm.2013.0278

Keywords

-

Categories

Health Care Sciences & Services

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Oncology

Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients

Xin Li, Xiaowei Chen, Xueju Hu, Yan Shen, Rui Xu, Leilei Wu, Xiaobing Shen

Summary: The study found that the GUCY1A2 gene is highly expressed in gastric cancer tissues and may serve as a potential prognostic marker. Logistic regression analysis showed that high expression of GUCY1A2 was significantly associated with histological grade and T stage. Kaplan-Meier curves indicated that gastric cancer patients with high expression of GUCY1A2 had a poorer prognosis. GSEA results demonstrated that the high GUCY1A2 phenotype is significantly enriched for tumor-related signaling pathways.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Downregulated CMTM8 Correlates with Poor Prognosis in Gastric Cancer Patients

Meng Yan, Xiaonian Zhu, Haizhi Qiao, Huiqing Zhang, Wenjie Xie, Jianhui Cai

Summary: CMTM8 protein is downregulated in gastric cancer tissues, and its expression is associated with metastasis and prognosis of gastric cancer patients.

DNA AND CELL BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer

Miguel A. Ortega, Oscar Fraile-Martinez, Leonel Pekarek, Cielo Garcia-Montero, Miguel Angel Alvarez-Mon, Alejandro J. Castellanos, Natalio Garcia-Honduvilla, Julia Bujan, Melchor Alvarez-Mon, Miguel A. Saez, Luis G. Guijarro, Angel Asunsolo

Summary: Pancreatic cancer is a malignancy that is becoming more prevalent, especially in developed countries due to dietary patterns and sedentary lifestyles. It is expected to become the second leading cause of cancer-related deaths in the near future. The low survival rate is attributed to the lack of symptoms in the early stages, leading to metastasis in advanced stages. This study evaluates molecular biomarkers and finds a correlation between their high expression and low survival rate in pancreatic cancer patients.

ANTIOXIDANTS (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy

Yan-Chih Peng, Chien-Hui Wu, Yu-Wen Tien, Tzu-Pin Lu, Yu-Hsin Wang, Bang-Bin Chen

Summary: Preoperative sarcopenia assessed by CT is a poor prognostic factor for overall survival in pancreatic cancer patients after pancreaticoduodenectomy (PD).

EUROPEAN RADIOLOGY (2021)

Add to Collection

Article Chemistry, Medicinal

Statin Use in Cancer Patients with Acute Myocardial Infarction and Its Impact on Long-Term Mortality

Konrad Stepien, Karol Nowak, Natalia Kachnic, Grzegorz Horosin, Piotr Walczak, Aleksandra Karcinska, Tomasz Schwarz, Mariusz Wojtas, Magdalena Zalewska, Maksymilian Pastuszak, Bogdan Wegrzyn, Jadwiga Nessler, Jaroslaw Zalewski

Summary: The use of statins in the treatment of myocardial infarction patients has a significant impact on long-term clinical outcomes, and this impact is even more crucial in patients with active cancer.

PHARMACEUTICALS (2022)

Add to Collection

Article Genetics & Heredity

High Expression of FCRLB Predicts Poor Prognosis in Patients With Colorectal Cancer

Xiaopeng Wang, Ruirong Lin, Yi Zeng, Yi Wang, Shenghong Wei, Zhitao Lin, Shu Chen, Zaisheng Ye, Luchuan Chen

Summary: In this study, the potential prognostic value of FCRLB in colorectal cancer (CRC) was identified through TCGA database analysis. FCRLB was found to be highly expressed in CRC tissues compared to normal tissues. High expression of FCRLB correlated with adverse clinicopathological features such as elevated CEA levels, advanced tumor stage, lymphatic invasion, perineural invasion, and incomplete resection. Additionally, high expression of FCRLB was associated with poorer overall survival, disease-specific survival, and progression-free survival. Further validation using tissue microarray confirmed these findings.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Hematology

Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era

Elsa Branvall, Sara Ekberg, Sandra Eloranta, Tove Wasterlid, Brenda M. Birmann, Karin E. Smedby

Summary: The study found that the use of statins was not consistently associated with any mortality outcome in NHL/CLL patients. For FL patients receiving active treatment, statin use did not increase lymphoma-specific mortality. However, in CLL patients, statin use was associated with all-cause and cardiovascular mortality but not consistently with lymphoma-specific mortality.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study

Sami Erkinantti, Ari Hautakoski, Reijo Sund, Martti Arffman, Elina Urpilainen, Ulla Puistola, Esa Laara, Arja Jukkola, Peeter Karihtala

Summary: This study investigated the association between the use of metformin and statins and the prognosis of colorectal cancer in patients with type 2 diabetes. The results showed no significant association between metformin use and colorectal cancer mortality, but statin use was found to be inversely associated with mortality from colorectal cancer.

BIOMOLECULES (2022)

Add to Collection

Article Oncology

FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer

Guoqing Li, Qiulei Wu, Lanqing Gong, Xiaohan Xu, Jing Cai, Linjuan Xu, Ya Zeng, Xiaoqi He, Zehua Wang

Summary: In early-stage CCa patients, FABP4 may serve as a promising biomarker for LNM and survival, and could potentially contribute to the development of personalized prognosis prediction and therapy optimization.

CANCER CELL INTERNATIONAL (2021)

Add to Collection

Article Oncology

High expression of SMARCC1 predicts poor prognosis in gastric cancer patients

Sheng Liu, Xinghua Cao, Shaobin Wu

Summary: The study found that SMARCC1 is frequently upregulated in gastric cancer and is significantly associated with clinical pathological factors such as tumor size, differentiation, depth of invasion, lymph node involvement, and TNM stage. Furthermore, high expression of SMARCC1 predicts poor prognosis in gastric cancer patients and may serve as a prognostic biomarker and therapeutic target in gastric cancer.

AMERICAN JOURNAL OF CANCER RESEARCH (2022)

Add to Collection

Article Oncology

Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients

Yuan Li, Hao Huang, Yulan Zhu, Bin Xu, Junjun Chen, Yingting Liu, Xiao Zheng, Lujun Chen

Summary: This study found that METTL3 expression is increased in pancreatic cancer tissues and is associated with the progression and prognosis of the disease. Additionally, METTL3 expression is related to tumor-infiltrating immune cells and m(6)A modification and metabolism in pancreatic cancer tissues.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer

Shujie Wang, Wenjing Liu, Yueli Ni, Lifeng Wang, Yuzhi Zhu, Qiong Shi, Zihan Yi, Wenjie Wang, Lili Liu, Lijuan Yang, Yingmin Kuang, Yuechun Zhu, Qiao Zhang, Zhe Yang

Summary: ERCC3 is overexpressed in pancreatic cancer and is associated with tumor extent and poor overall survival. In vitro studies showed that overexpression of ERCC3 promoted proliferation, invasion, and migration of pancreatic cancer cells. These findings suggest that ERCC3 may serve as a potential therapeutic target for pancreatic cancer treatment.

JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients

Wei Wen, Baohong Jiang, Xi Cao, Liming Xie, Xiaoli Zhang, Yuehua Li, Rongfang He

Summary: Our study found that low CRIM1 expression predicts poor prognosis in breast cancer and CRIM1 could potentially serve as a treatment target or prognostic marker. We observed downregulation of CRIM1 in various subtypes of breast cancer, particularly in triple-negative breast cancers. The expression of CRIM1 was positively correlated with ER and PR status, while negatively correlated with HER-2 expression. We also found associations between CRIM1 expression and clinicopathological characteristics of breast cancer, as well as immune infiltration patterns. Further research is needed to fully understand the prognostic value of CRIM1 in breast cancer.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

ASPECTS-based net water uptake predicts poor reperfusion and poor clinical outcomes in patients with ischemic stroke

Shan-Shan Lu, Rong-Rong Wu, Yue-Zhou Cao, Xiao-Quan Xu, Shu-Shen Lin, Sheng Liu, Hai-Bin Shi, Fei-Yun Wu

Summary: The study found that automated ASPECTS-based NWU can predict tissue-level reperfusion status and 90-day functional outcomes in acute ischemic stroke patients after reperfusion therapy. Patients with higher NWUFCT and Delta NWU had poor reperfusion despite successful recanalization. Delta NWU was an independent predictor of poor reperfusion and unfavorable neurological outcomes.

EUROPEAN RADIOLOGY (2022)

Add to Collection

Article Oncology

The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients

Longhai Li, Kai Jiang, Dongpeng Li, Dongxiao Li, Zitong Fan, Guosheng Dai, Sheng Tu, Xiangyu Liu, Guangyou Wei

Summary: The study finds that high expression of CXCL7 is correlated with VEGF expression and poor prognosis in CRC patients. The combined expression of CXCL7 and VEGF can better predict patients' survival time.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Protocol for a pilot and feasibility study of nurse practitioner-pharmacist telehealth collaboration to simplify complex medication regimens

J. Simon Bell, Choon Ean Ooi, Lakkhina Troeung, Sheila Craik, Rebecca Walton, Angelita Martini

Summary: This study aims to investigate the feasibility of a nurse practitioner-pharmacist telehealth-based collaborative care model to simplify complex medication regimens in residential aged care facilities. The study will be conducted in 4 RACFs in Western Australia, with up to 30 permanent residents. Nurse practitioners and clinical pharmacists will work together to assess and simplify medication regimens, and potential outcomes will be evaluated. The findings of this study will be disseminated through various channels, including industry reports and peer-reviewed publications.

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2022)

Add to Collection

Article Geriatrics & Gerontology

Treatment initiation for parkinson's disease in Australia 2013-2018: a nation-wide study

Marjaana Koponen, J. Simon Bell, Samanta Lalic, Rosie Watson, Anne M. Koivisto, Jenni Ilomaki

Summary: The study in Australia examined the initiation of anti-Parkinson medication, with levodopa being the most commonly used drug followed by non-ergot dopamine agonists. Among individuals aged 65 and above, initiation with levodopa was most frequent, in line with current guidelines.

BMC GERIATRICS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized

Stephen J. Wood, J. Simon Bell, Dianna J. Magliano, Jonathan E. Shaw, Matteo Cesari, Jenni Ilomaki

Summary: This study found that in frail individuals with type 2 diabetes, the use of SGLT-2Is may be more effective in reducing MACE, HF hospitalizations, and mortality compared to DPP-4Is.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Using primary care data to understand opioid prescribing, policy impacts and clinical outcomes: A protocol for the OPPICO study

Helena Cangadis-Douglass, Monica Jung, Ting Xia, Rachelle Buchbinder, Samanta Lalic, Grant Russell, Nadine Andrew, Christopher Pearce, J. Simon Bell, Jenni Ilomaki, Suzanne Nielsen

Summary: This study aims to examine the impact of recent policy changes and clinical guidelines on opioid prescribing in primary care in Australia. It will analyze longitudinal data to evaluate the effects of these changes and identify strategies for optimizing opioid prescribing in primary care.

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2022)

Add to Collection

Editorial Material Pharmacology & Pharmacy

EMBEDDING PHARMACISTS IN RESIDENTIAL AGED CARE: WHY IT'S IMPORTANT TO INTEGRATE RESIDENT - AND SYSTEM-LEVEL SERVICES

Amanda J. Cross, Adam La Caze, Michelle Steeper, J. Simon Bell

JOURNAL OF PHARMACY PRACTICE AND RESEARCH (2022)

Add to Collection

Article Pharmacology & Pharmacy

COVID-19 restrictions and the incidence and prevalence of prescription opioid use in Australia - a nationwide study

Monica Jung, Dickson Lukose, Suzanne Nielsen, J. Simon Bell, Geoffrey Webb, Jenni Ilomaki

Summary: The COVID-19 pandemic has disrupted healthcare seeking and delivery, and different Australian jurisdictions implemented varying restrictions. Analyzing national pharmacy dispensing data in Australia, it was found that after nationwide COVID-19 restrictions, the incidence and prevalence of opioid dispensing decreased in Victoria, New South Wales, and other jurisdictions. However, in Victoria post-lockdown, both the incidence and prevalence increased. There were no significant changes in the initiation of long-term opioid use in any jurisdiction. More stringent restrictions were associated with greater reductions in overall opioid initiation, but not in long-term opioid use initiation.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Add to Collection

Article Substance Abuse

What are the research priorities for optimising the safe and effective use of opioids in Australian general practice?

Monica Jung, Helena Cangadis-Douglass, Suzanne Nielsen, Samanta Lalic, Malcolm Dobbin, Grant Russell, Pallavi Prathivadi, Pene Wood, Elizabeth Manias, Cik Y. Lee, Carolyn Arnold, Megan Kuleas, Jennifer L. Schumann, Jenni Ilomaki, J. Simon Bell

Summary: This study identified research priorities for the safe and effective use of prescription opioids in Australian general practice through a structured consensus workshop involving consumers, clinicians, and policymakers. The highest ranked research priorities were consumer characteristics influencing opioid prescribing and outcomes, opioid deprescribing strategies, and system-level barriers to prescribing alternatives to opioids. These priorities provide a roadmap for future research to inform safe and effective opioid prescribing.

DRUG AND ALCOHOL REVIEW (2023)

Add to Collection

Article Geriatrics & Gerontology

Provider knowledge, beliefs, and self-efficacy to deprescribe opioids and sedative-hypnotics

Shelly L. Gray, Rachyl Fornaro, Justin Turner, Denise M. Boudreau, Robert Wellman, Cara Tannenbaum, Zachary A. Marcum, Benjamin Balderson, Andrea Cook, Anna Liss Jacobsen, Elizabeth A. Phelan

Summary: This study found that patient willingness, withdrawal symptoms, and time constraints are the major factors influencing deprescribing from the provider perspective. Providers have knowledge gaps and lack self-efficacy in opioid and sedative-hypnotic deprescribing.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Did Australia's COVID-19 Restrictions Impact Statin Incidence, Prevalence or Adherence?

Adam C. Livori, Dickson Lukose, J. Simon Bell, Geoffrey I. Webb, Jenni Ilomaki

Summary: COVID-19 restrictions did not result in significant changes in the incidence, prevalence, or adherence to statins in Australia. Adaptive interventions, such as telehealth consultations and medication delivery, successfully maintained access to cardiovascular medications.

CURRENT PROBLEMS IN CARDIOLOGY (2023)

Add to Collection

Article Geriatrics & Gerontology

The impact of educational whiteboard videos on healthcare providers' self-efficacy to deprescribe

Justin P. Turner, Camille L. Gagnon, Ninh B. Khuong, Emily G. McDonald, Cara Tannenbaum

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2023)

Add to Collection

Article Education, Scientific Disciplines

A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing

Barbara Farrell, Lalitha Raman-Wilms, Cheryl A. Sadowski, Laurie Mallery, Justin Turner, Camille Gagnon, Mollie Cole, Allan Grill, Jennifer E. Isenor, Dee Mangin, Lisa M. McCarthy, Brenda Schuster, Caroline Sirois, Winnie Sun, Ross Upshur

Summary: The article presents a proposed pre-licensure competency framework that outlines essential knowledge, teaching strategies, and assessment protocols to enhance interprofessional deprescribing skills. It also emphasizes the inclusion of patients and care partners in deprescribing decisions and provides an action plan and curriculum mapping exercise for educators to evaluate and integrate these concepts and strategies into their programs. The goal is to ensure that learners graduate with the necessary competencies to manage complex medication regimens as individuals age.

MEDICAL SCIENCE EDUCATOR (2023)

Add to Collection

Article Rehabilitation

Barriers and facilitators to reducing paracetamol use in low back pain: A qualitative study

Thomas Patterson, Paula R. Beckenkamp, Justin Turner, Danijela Gnjidic, Barbara Mintzes, Carol Bennett, Lisa Bywaters, Ornella Clavisi, Melissa Baysari, Manuela Ferreira, Paulo Ferreira

Summary: This study aimed to explore the barriers and facilitators of deprescribing paracetamol for low back pain patients. The results showed that support from healthcare professionals, patient willingness, perceived necessity and risk awareness, effort, and varied strategies all influence the outcomes of deprescribing.

MUSCULOSKELETAL SCIENCE AND PRACTICE (2023)

Add to Collection

Article Medicine, General & Internal

Deprescribing proton pump inhibitors

Justin P. Turner, Wade Thompson, Emily Reeve, J. Simon Bell

Summary: Long-term and high-dose use of PPIs may increase the risk of adverse events and should be considered for deprescribing. Gradual dose reduction and consideration of as-needed use are recommended to avoid rebound acid hypersecretion symptoms caused by abrupt discontinuation.

AUSTRALIAN JOURNAL OF GENERAL PRACTICE (2022)

Add to Collection

Letter Psychiatry

Clozapine and the risk of haematological malignancies Reply

Jari Tiihonen, Antti Tanskanen, J. Simon Bell, Jessica L. Dawson, Vesa Kataja, Heidi Taipale

LANCET PSYCHIATRY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.